Life Seal Vascular has announced the appointment of Matt Thompson as chief executive officer (CEO).
A company press release has stated that Thompson’s career as a vascular surgeon and medical device executive positions Life Seal Vascular to accelerate the development and commercialisation of its vascular technologies.
“We are thrilled to welcome Thompson as our CEO,” said Robert Mitchell, executive chairman of Life Seal Vascular. “His unique combination of clinical expertise and executive leadership in the vascular medical device industry makes him the ideal leader to drive our next phase of growth. His prior service on our board has provided him with deep insight into our company’s mission and we are excited for his leadership as we advance our technologies into clinical use.”
From 2002 to 2016, Thompson served as a leading vascular surgeon at St. George’s Hospital in London, UK, where he gained international recognition for his expertise in complex aortic repair, the company states. Transitioning to the medical device industry, he held key leadership roles, serving as chief medical officer at Endologix from 2016–2021 and chief executive officer from 2021–2025. He currently continues to contribute to Endologix as chief medical officer.
“I am honoured to join Life Seal Vascular at this pivotal stage,” said Thompson. “The company is developing breakthrough endovascular solutions that address critical unmet clinical needs, particularly in the prevention of type II endoleaks following endovascular aneurysm repair. I look forward to working with the team to bring these innovations to patients and clinicians worldwide.”
